Meningococcal Vaccination Schedules Updated by French medical Federation
Paris, France – 2025/12/06 16:28:38 CET – The Fédération des Médecins de France (FMF) has released updated guidelines regarding meningococcal vaccination schedules, impacting individuals from infancy through adulthood. The revised recommendations, published today, detail specific vaccination timing based on age, aiming to optimize protection against invasive meningococcal disease.
Meningococcal disease, a serious bacterial infection of the membranes surrounding the brain and spinal cord, can cause severe illness and even death.the FMF’s updated guidance clarifies vaccination protocols for different age groups, addressing variations in dosage intervals, particularly for infants initiating vaccination before the age of two. These updates are crucial for healthcare professionals and families to ensure thorough and timely protection against this potentially life-threatening illness.
The FMF specifies vaccination schedules as follows: for individuals aged two years and older, the recommended vaccines are M0 and M1. For children vaccinated before the age of two, the interval between the second and third doses varies depending on the age at which vaccination commenced.
The FMF’s detailed recommendations are available on their website, alongside supporting materials for healthcare providers. These resources aim to facilitate consistent application of the updated protocols across France,bolstering public health efforts to combat meningococcal disease.
